Singular Genomics Systems, Inc. financial data

Symbol
OMIC on Nasdaq
Industry
Laboratory Analytical Instruments
Location
3010 Science Park Road, San Diego, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.25K % -39.1%
Quick Ratio 85.4 % -28.2%
Debt-to-equity 42.5 % +69%
Return On Equity -51.1 % -48.5%
Return On Assets -35.9 % -30.4%
Operating Margin -4.19K % +29.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 74.1M shares +2.86%
Common Stock, Shares, Outstanding 74.1M shares +2.88%
Entity Public Float 49M USD -77.1%
Common Stock, Value, Issued 7K USD 0%
Weighted Average Number of Shares Outstanding, Basic 73.9M shares +2.78%
Weighted Average Number of Shares Outstanding, Diluted 73.9M shares +2.78%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.49M USD +52.9%
Cost of Revenue 3.52M USD +121%
Research and Development Expense 47M USD -1.58%
Operating Income (Loss) -104M USD -7.67%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -96.2M USD -4.01%
Earnings Per Share, Basic -1.31 USD/shares -0.77%
Earnings Per Share, Diluted -1.31 USD/shares -0.77%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 24.1M USD -81.4%
Cash, Cash Equivalents, and Short-term Investments 151M USD -33.3%
Inventory, Net 13.1M USD -23.8%
Assets, Current 166M USD -32.5%
Property, Plant and Equipment, Net 13.9M USD +23%
Operating Lease, Right-of-Use Asset 57.1M USD +27.2%
Other Assets, Noncurrent 1.08M USD -6.42%
Assets 239M USD -21.7%
Accounts Payable, Current 2.01M USD +1.77%
Accrued Liabilities, Current 3.27M USD -2.63%
Liabilities, Current 16.1M USD +28.7%
Operating Lease, Liability, Noncurrent 58.1M USD +39.8%
Other Liabilities, Noncurrent 605K USD -39.4%
Liabilities 82.4M USD +26.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -51K USD +87%
Retained Earnings (Accumulated Deficit) -363M USD -36.1%
Stockholders' Equity Attributable to Parent 157M USD -34.8%
Liabilities and Equity 239M USD -21.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -23.7M USD -32.2%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 31.6M USD -56.7%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 74.1M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 7.88M USD -85.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 24.7M USD -81.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 246K USD +13.9%
Deferred Tax Assets, Valuation Allowance 86.2M USD +45%
Deferred Tax Assets, Gross 102M USD +40.4%
Operating Lease, Liability 65.9M USD +35.9%
Depreciation 1.02M USD +28.5%
Payments to Acquire Property, Plant, and Equipment 25K USD -84.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -95.9M USD -4.06%
Lessee, Operating Lease, Liability, to be Paid 117M USD +36.9%
Property, Plant and Equipment, Gross 22.9M USD +37.9%
Operating Lease, Liability, Current 7.82M USD +12.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.72M USD +2.81%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.1M USD -21.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +11%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 179M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.61M USD +54.7%
Deferred Tax Assets, Operating Loss Carryforwards 54.3M USD +35.3%
Unrecognized Tax Benefits 2.22M USD +79.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.58M USD +57.5%
Additional Paid in Capital 519M USD +2.41%
Deferred Tax Assets, Net of Valuation Allowance 15.7M USD +19.5%
Share-based Payment Arrangement, Expense 11.2M USD -14.9%
Interest Expense 1.13M USD +28%